These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer. Sandler RS. Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132 [Abstract] [Full Text] [Related]
5. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer. Luk GD. Schweiz Med Wochenschr; 1996 May 11; 126(19):801-12. PubMed ID: 8693304 [Abstract] [Full Text] [Related]
9. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. González-Pérez A, García Rodríguez LA, López-Ridaura R. BMC Cancer; 2003 Oct 31; 3():28. PubMed ID: 14588079 [Abstract] [Full Text] [Related]
10. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk. Howard PA, Delafontaine P. J Am Coll Cardiol; 2004 Feb 18; 43(4):519-25. PubMed ID: 14975457 [Abstract] [Full Text] [Related]
11. Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer. Hahn E, Kraus S, Arber N. Dig Dis; 2010 Feb 18; 28(4-5):585-9. PubMed ID: 21088406 [Abstract] [Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer. Pereg D, Lishner M. J Intern Med; 2005 Aug 18; 258(2):115-23. PubMed ID: 16018788 [Abstract] [Full Text] [Related]
13. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer]. Wei WQ, Qiao YL. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb 18; 23(1):78-82. PubMed ID: 12905826 [Abstract] [Full Text] [Related]
14. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? Gill S, Sinicrope FA. Semin Oncol; 2005 Feb 18; 32(1):24-34. PubMed ID: 15726503 [Abstract] [Full Text] [Related]
15. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I. Moyad MA. Semin Urol Oncol; 2001 Nov 18; 19(4):294-305. PubMed ID: 11769881 [Abstract] [Full Text] [Related]
16. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Limmer S, Ittel TH, Wietholtz H. Z Gastroenterol; 2003 Aug 18; 41(8):719-28. PubMed ID: 12910426 [Abstract] [Full Text] [Related]
17. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Schrör K. Best Pract Res Clin Gastroenterol; 2011 Aug 18; 25(4-5):473-84. PubMed ID: 22122764 [Abstract] [Full Text] [Related]
18. Genetic tools to tailor cancer prevention by NSAIDs. Ulrich CM, Bigler J, Potter JD. Discov Med; 2006 Apr 18; 6(32):71-4. PubMed ID: 17234129 [Abstract] [Full Text] [Related]
19. Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs. Hilmi I, Goh KL. Chin J Dig Dis; 2006 Apr 18; 7(1):1-6. PubMed ID: 16412030 [Abstract] [Full Text] [Related]
20. [A 100 years of aspirin: a drug with a future?]. Sánchez García P. An R Acad Nac Med (Madr); 1997 Apr 18; 114(1):157-63; discussion 164-7. PubMed ID: 9324911 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]